Neuvonique Research Remedies Private Limited - Company Profile

It is a research & development private limited company based in Panvel, Maharashtra, India, established in 2017.
2017 Panvel, Maharashtra, India Active
Last Updated:
Access Report
About Neuvonique Research Remedies Private Limited

Neuvonique Research Remedies Private Limited, a active private limited company, was established on 22 September 2017 in Panvel, Maharashtra, India. Engaging in science research within the research & development sector, it holds CIN: U73100MH2017PTC300017. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Sachin Ashok Shanbhag (Director), Prakash Santoshrao Parhad (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-201 Gurudeo Chs, Plot No 27, Sector 20, Kamothe, Panvel, Raigarh, Panvel, Maharashtra, 410209.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100MH2017PTC300017

  • Registration Number

    300017

  • Incorporation Date

    22 September 2017

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 45.33%
  • Ebitda **** 45.33%
  • Total Assets **** %
Company report

Neuvonique Research Remedies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neuvonique Research Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Neuvonique Research Remedies Private Limited?
Current Directors
Name Designation Appointment Date Status
Sachin Ashok Shanbhag Director 22 Sep 2017 Current
Prakash Santoshrao Parhad Director 22 Sep 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neuvonique Research Remedies.

Neuvonique Research Remedies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 45.33% increase in profit. The company's net worth witnessed no change by increase of 0%.

Neuvonique Research Remedies revenue growth over time
Neuvonique Research Remedies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
 45.33%
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
 45.33%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neuvonique Research Remedies?

Unlock access to Neuvonique Research Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Neuvonique Research Remedies?

Unlock and access historical data on people associated with Neuvonique Research Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neuvonique Research Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuvonique Research Remedies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neuvonique Research Remedies
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Neuvonique Research Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Neuvonique Research Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii. was recorded as a recent event.

  • Director Appointment

    The activity Sachin Ashok Shanbhag was appointed as a Director was appointed as a Director on 22 Sep 2017 & has been associated with this company since 8 years 5 months . was completed.

  • Director Appointment

    The activity Prakash Santoshrao Parhad was appointed as a Director was appointed as a Director on 22 Sep 2017 & has been associated with this company since 8 years 5 months . was completed.

  • Company Incorporation

    The activity Neuvonique Research Remedies Private Limited was registered on 22 Sep 2017 with Roc Mumbai Ii & aged 8 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neuvonique Research Remedies Private Limited?

The CIN of Neuvonique Research Remedies Private Limited is U73100MH2017PTC300017.

Where is Neuvonique Research Remedies Private Limited headquartered?

Neuvonique Research Remedies Private Limited is headquartered at A-201 Gurudeo Chs, Plot No 27, Sector 20, Kamothe, Panvel, Raigarh, Panvel, Maharashtra, 410209.

When was Neuvonique Research Remedies Private Limited incorporated?

Neuvonique Research Remedies Private Limited was incorporated on 22 September 2017.

Who are the current directors of Neuvonique Research Remedies Private Limited?

The current directors of Neuvonique Research Remedies Private Limited are

What is the primary industry of Neuvonique Research Remedies Private Limited?

The primary industry of Neuvonique Research Remedies Private Limited is Research & Development.

Is Neuvonique Research Remedies Private Limited a listed company?

Neuvonique Research Remedies Private Limited is unlisted.

What is the capital structure of Neuvonique Research Remedies Private Limited?

The authorized capital of Neuvonique Research Remedies Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Neuvonique Research Remedies Private Limited?

The compliance status of Neuvonique Research Remedies Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available